Faculty Presentations

Late-Breaking Abstract Presenter: Matthew A. Powell, MD
Abstract Title: Overall survival in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY
Date/Time: 3/16/2024 | 8:30 – 9:45 AM


Poster Session I – Hall GH
Date/Time: 3/17/2024 | 1:15 ‐ 2:45 PM

Abstract Title: Factors influencing gynecologic risk reduction surgeries for BRCA1 or BRCA2 germline mutation carriers
Poster Presenter: Andrea R. Hagemann, MD, MSci

Abstract Title: Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE Study
Poster Presenter: Premal H. Thaker, MD, MS

Abstract Title: COPS5 inhibition targets nucleotide excision repair and homologous recombination to enhance platinum chemotherapy response in ovarian cancer
Poster Presenter: Mary M. Mullen, MD


Poster Session II – Hall GH
Date/Time: 3/18/2024 | 11:45 ‐ 12:45 PM

Abstract Title: Advanced cervical cancer patients value disease control in addition to overall survival in treatment decision making: A U.S. patient preference study
Poster Presenter: Premal H. Thaker, MD